Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dihydroartemisinin–piperaquine versus sulfadoxine–pyrimethamine for malaria prevention during pregnancy
PACTR202002644579177Unknown
- Sponsor
- Royal Society of Tropical Medicine and Hygiene
- Start
- Mar 2020
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Trial of dihydroartemisinin, piperaquine, sulfadoxine and pyrimethamine in malaria (2 arms), sponsored by Royal Society of Tropical Medicine and Hygiene. Primary endpoint: Peripheral and/or placental parasitaemia. Status: unknown.
02
Drugs
dihydroartemisininpiperaquinesulfadoxinepyrimethamine
03
Conditions
malaria
Beyond the preview
Go deeper on PACTR202002644579177.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202002644579177.